TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06112652

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: 4 session rTMS
Description: Participants will receive 4 sessions per day of 1800 pulses per session, lasting for 5 days. Individualized targets will be generated using the pBFS method.
Study: NCT05264077

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine Hydrochloride
Description: Inj dexmedetomidine and inj midazolam given to two groups of participants and effects of both drugs will be observed for 24 hrs
Study: NCT06112652

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: 6 session rTMS
Description: Participants will receive 6 sessions per day of 1800 pulses per session, lasting for 5 days. Individualized targets will be generated using the pBFS method.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: 8 session rTMS
Description: Participants will receive 8 sessions per day of 1800 pulses per session, lasting for 5 days. Individualized targets will be generated using the pBFS method.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: 10 session rTMS
Description: Participants will receive 10 sessions per day of 1800 pulses per session, lasting for 5 days. Individualized targets will be generated using the pBFS method.

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: sham rTMS
Description: The parameters in the sham arms are the same as the active stimulation groups. Stimulation was delivered by the same device as the active group fitted with a sham coil.
Study: NCT06427031

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TJO-083
Description: Diquafosol ophthalmic sodium solution, 1 drop 3 times a day

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Diquafosol ophthalmic sodium solution 3%
Description: Diquafosol ophthalmic sodium solution, 1 drop 6 times a day
Study: NCT05434182

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Intradermal Suture
Description: Skin closure with an intradermal suture using Monosyn® (Braun®) 4/0 absorbable monofilament.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Metallic Staples
Description: Skin closure with metallic stapling using Visistat® (Weck®) 35W skin stapler.
Study: NCT06092489

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: graded motor imagery
Description: The three different treatment techniques include left/right discrimination training, explicit motor imagery exercises and mirror therapy. These techniques are delivered sequentially but require a flexible approach from the patient and clinician to move forwards, backward and sideways in the treatment process to suit the individual. With patience, persistence and often lots of hard work, GMI gives new hope for treatment outcomes.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: traditional physiotherapy method
Description: This protocol included stretching and strengthening exercises. Self-stretching will encapsulate the upper trapezius, pectoralis minor, posterior. Each stretch will consist of 3 repetitions of 30 seconds with a 30 second break between repetitions. Strengthening exercises will be performed using elastic resistance bands (Theraband ®) with 4 levels of resistance (red, green, blue and grey). Sets can be easily changed (without the person reporting muscle fatigue) and progressed with resistance. The therapist will ask about the level of effort required for exercise exercises and whether it would be possible to increase the resistance level. The exercise consists of three sets of 10 repetitions and is completed with 1 rest between them. Strengthening exercises will include prone extension, prone external rotation with abduction, side lying external rotation and serratus anterior strengthening.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: traditional physiotherapy method
Description: This protocol included stretching and strengthening exercises. Self-stretching will encapsulate the upper trapezius, pectoralis minor, posterior. Each stretch will consist of 3 repetitions of 30 seconds with a 30 second break between repetitions. Strengthening exercises will be performed using elastic resistance bands (Theraband ®) with 4 levels of resistance (red, green, blue and grey). Sets can be easily changed (without the person reporting muscle fatigue) and progressed with resistance. The therapist will ask about the level of effort required for exercise exercises and whether it would be possible to increase the resistance level. The exercise consists of three sets of 10 repetitions and is completed with 1 rest between them. Strengthening exercises will include prone extension, prone external rotation with abduction, side lying external rotation and serratus anterior strengthening.
Study: NCT05990101

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Awake prone position (APP)
Description: Awake prone position for 4 or more hours per day for the first 72 hours following randomisation.
Study: NCT06309212

Intervention type: OTHER
Intervention: Observation
Description: Analyse of data from adults with respiratory tract infections who were tested for various respiratory viruses using a multiplex PCR assay

Intervention type: OTHER
Intervention: Observation
Description: Analyse of data from adults with respiratory tract infections who were tested for various respiratory viruses using a multiplex PCR assay
Study: NCT06221904

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Simple Gymnastics Training
Description: This is a simple gymnastics training that includes body swings and waist twists, as well as exercises targeting the joints in the arms and legs in various directions. It aims to help Parkinson's patients improve their physical mobility. Each training session lasts for 30 minutes, with low intensity and easy to stick to.
Study: NCT06474208

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Formulation 4
Description: Oral suspension of Vericiguat (BAY1021189) with increased level of sucralose and flavor in SD.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Formulation 4
Description: Oral suspension of Vericiguat (BAY1021189) with increased level of sucralose and flavor in SD.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Formulation 4
Description: Oral suspension of Vericiguat (BAY1021189) with increased level of sucralose and flavor in SD.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Formulation 5 (placebo)
Description: Matching placebo of formulation 1 in SD.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Formulation 5 (placebo)
Description: Matching placebo of formulation 1 in SD.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Formulation 5 (placebo)
Description: Matching placebo of formulation 1 in SD.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Formulation 5 (placebo)
Description: Matching placebo of formulation 1 in SD.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Formulation 5 (placebo)
Description: Matching placebo of formulation 1 in SD.
Study: NCT06008275

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Neratinib Oral Tablet
Description: 240mg oral daily. Dosing will follow standard dose escalation procedures

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ruxolitinib Oral Tablet
Description: 20mg oral twice daily. Dosing will follow standard initial dose recommendation procedure
Study: NCT05056623

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Dyadic pain management program
Description: Face-to-face part: The DPM will start with 20-30 minutes of physical exercise supervised by research assistant, followed by 20-minutes of pain management education. Communication skills regarding the practice of various pain management techniques by the participants and their caregivers will be taught. At the end of the session, the caregiver and research assistant will help the older adults to make portfolio entries on the activities of the day, to help them recall the various pain-relief methods learned in each class.~Home-based part: An exercise book will be given to guide them in performing exercises at home. It is recommended to perform 30 minutes of exercise, 3 times a week, at home and the more frequent the exercise time, the better.~All participants will join a WhatsApp group to receive teaching materials and videos of the physical exercises learned, for practice at home. The team will produce compact disc (CD) with the exercise video clips to the dyads for revision.

Intervention type: OTHER
Group type: OTHER
Intervention: Usual care and pain management pamphlet
Description: Usual care and pain management pamphlet
Study: NCT06137625

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: With regular rhythm
Description: All children learn one dance choreographie with regular rhythm music.The pre-recorded choreography is displayed on a large screen in front of the child. The child practices the choreography by imitating the models in order to learn the sequence movements.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: With regular rhythm
Description: All children learn one dance choreographie with regular rhythm music.The pre-recorded choreography is displayed on a large screen in front of the child. The child practices the choreography by imitating the models in order to learn the sequence movements.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Without regular rhythm
Description: All children learn one dance choreographie without regular rhythm music.The pre-recorded choreography is displayed on a large screen in front of the child. The child practices the choreography by imitating the models in order to learn the sequence movements.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Without regular rhythm
Description: All children learn one dance choreographie without regular rhythm music.The pre-recorded choreography is displayed on a large screen in front of the child. The child practices the choreography by imitating the models in order to learn the sequence movements.
Study: NCT04722146

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Teclistamab
Description: Participants will receive teclistamab.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Teclistamab
Description: Participants will receive teclistamab.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Teclistamab
Description: Participants will receive teclistamab.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Teclistamab
Description: Participants will receive teclistamab.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Teclistamab
Description: Participants will receive teclistamab.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Teclistamab
Description: Participants will receive teclistamab.
Study: NCT05866120

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Physiotherapy on the ground
Description: Physical therapy will be performed on the ground, in 12 weeks, twice a week. The exercises will be based on a protocol developed by the researchers. This protocol has 15 exercises, aimed at muscle function and extensor musculature. All exercises can be adapted according to the severity of the individual, as well as the progression of these exercises will be made according to the adaptation and ease of individuals throughout the intervention.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Aquatic physiotherapy
Description: Aquatic physiotherapy will be performed in 12 weeks, twice a week, in shallow water. The exercises will be based on a protocol developed by the researchers. This protocol has 15 exercises, aimed at muscle function and extensor musculature. All exercises can be adapted according to the severity of the individual, as well as the progression of these exercises will be made according to the adaptation and ease of individuals throughout the intervention.
Study: NCT04392921

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Amiodarone
Description: Patients will undergo one of the two regimens of amiodarone, based on their ability to tolerate po (per os) intake in the post-operative period:~• All patient will receive 1050mg of amiodarone in 100mL of 5% dextrose administered intravenously initiated at the time of anesthesia induction at a rate of 0.73mg/min or 43.75mg/h and continued over 24 hours followed by:~* If able to tolerate po intake: 400mg po BID for post-operative days 1 to 5 or until the day of discharge (whichever occurs first).~* If unable to tolerate po intake: daily infusion of 1050mg in 100mL of 5% dextrose for postoperative days 1 to 5 or until the day of discharge (whichever occurs first).

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Patients will undergo one of the two schedules or intravenous infusion, based on their ability to tolerate po intake in the post-operative period:~* All patients will receive 100mL of 5% dextrose administered intravenously initiated at the time of anesthesia induction at a rate of 0.73mg/min or 43.75mg/h and continued over 24 hours followed by:~  o If able to tolerate po intake: 400mg po BID for post-operative days 1 to 5 or until the day of discharge (whichever occurs first).~* Esophagectomy patient will receive 100mL of 5% dextrose at the time of anesthesia induction at a rate of what would be 0.73mg/min or 43.75mg/h if it contained 1050mg of amiodarone, followed by daily infusion of 100mL of 5% dextrose for 4 days or until the day of discharge (whichever occurs first).
Study: NCT05825144

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Robotic exoskeleton-assisted gait rehabilitation
Description: Use a robotic exoskeleton for gait rehabilitation in addition to conventional rehabilitation

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional rehabilitation
Description: Regular post-stroke rehabilitation
Study: NCT05669586

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Antitumor therapy guided by organoid drug sensitivity test
Description: Antitumor therapy guided by organoid will be given to Multi-line Drug-resistant Non-small Cell Lung Cancer patients.
Study: NCT06608381

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Arm I (Total omentectomy),
Description: The surgery is performed with minimal invasive surgery, and the range of the surgery is radical gastrectomy and D2 lymph node dissection. Depending on the random assignment, total omentectomy and partial omentectomy (omentum preservation) will be performed for the control group and the experimental group, respectively. Total omentectomy removes whole greater omentum, while partial omentectomy preserves the omentum more than 3cm away from the gastro-epiploic vessels. Other surgical procedures are the same as usual in both groups.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Arm II (Partial omentectomy)
Description: The surgery is performed with minimal invasive surgery, and the range of the surgery is radical gastrectomy and D2 lymph node dissection. Depending on the random assignment, total omentectomy and partial omentectomy (omentum preservation) will be performed for the control group and the experimental group, respectively. Total omentectomy removes whole greater omentum, while partial omentectomy preserves the omentum more than 3cm away from the gastro-epiploic vessels. Other surgical procedures are the same as usual in both groups.
Study: NCT04722146

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Daratumumab
Description: Participants will receive daratumumab.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Daratumumab
Description: Participants will receive daratumumab.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Daratumumab
Description: Participants will receive daratumumab.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Daratumumab
Description: Participants will receive daratumumab.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pomalidomide
Description: Participants will receive pomalidomide.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lenalidomide
Description: Participants will receive lenalidomide.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lenalidomide
Description: Participants will receive lenalidomide.
Study: NCT04563130

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cryocompression
Description: Cryocompression will be administered using ice bags and compression socks/ surgical gloves
Study: NCT04819711

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Thinking Healthy Programme
Description: The Thinking Healthy Programme (THP) is an evidence-based intervention that is based on principles of cognitive behavioral therapy. It includes strategies that incorporate behavioral activation, active listening, collaboration with the family, guided discovery, and homework. The adapted THP consists of 5 integrated sessions. Session 1 introduces the programme and focuses on engagement of participants, introduction of THP, and breathing exercises. Session 2 focuses on psychoeducation and problem solving. Session 3 focuses on the mother's well-being and introduces activities such as physical exercises, good sleep practices and ensuring a balanced diet. Session 4 focuses on the mother's relationship with the unborn baby. Session 5 focuses on activating social support from family, friends and peers and provides closure of therapy.
Study: NCT04722146

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lenalidomide
Description: Participants will receive lenalidomide.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lenalidomide
Description: Participants will receive lenalidomide.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bortezomib
Description: Participants will receive bortezomib.
Study: NCT06309368

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Primary Ostomy Closure with 0.1% Betaine/0.1% Polyhexanide Wound Irrigation
Description: An elliptical transverse incision will be made extending 1-2 cm lateral and medial to the mucocutaneous junction. The mobilization, anastomosis and fascial closure will be performed as in the pursestring closure group. The incision will then be irrigated using direct stream into the wound with 350cc of Prontosan. After one minute the wound will be suctioned dry. The subcutaneous fat will be mobilized and approximated with interrupted 2-0 Vicryl. The skin will be approximated with deep dermal 3-0 Vicryl and a running subcuticular 4-0 Monocryl suture and Dermabond will be applied.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Pursestring Closure
Description: A circular incision will be made at the mucocutaneous junction of the ileostomy. After complete mobilization of the ileal limbs off the fascia and a stapled side to side functional end to end anastomosis, the fascia including the external and posterior rectus sheath will be closed with two running #0 PDS (Polydioxanone) suture. The wound will then be irrigated with saline and partially closed in the subcuticular plane with a 2-0 Monocryl suture in a pursestring fashion and packed in the middle with plain packing.
Study: NCT05669144

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: mitochondria and MSC-derived exosomes
Description: autologous mitochondria and MSC-derived exosomes

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: mitochondria and MSC-derived exosomes
Description: autologous mitochondria and MSC-derived exosomes

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: mitochondria and MSC-derived exosomes
Description: autologous mitochondria and MSC-derived exosomes

Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: mitochondria and MSC-derived exosomes
Description: autologous mitochondria and MSC-derived exosomes
Study: NCT04722146

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bortezomib
Description: Participants will receive bortezomib.
Study: NCT05042804

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Machine learning models predicting postoperative death and acute kidney injury
Description: The machine learning display uses data from the electronic health record to predict the likelihood of postoperative death and postoperative acute kidney injury.
Study: NCT05603481

Intervention type: DEVICE
Intervention: Continuous Glucose Monitor
Description: Patients will wear a CGM device on their arm for 10 days, while receiving standard of care blood draws and finger stick sugar checks.
Study: NCT04722146

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nirogacestat
Description: Participants will receive nirogacestat.
Study: NCT04384835

Intervention type: BIOLOGICAL
Intervention: Blood sample collection (one tube)
Description: Collection of one tube of 7.5 ml blood in addition to a blood sample made in clinical practice

Intervention type: BIOLOGICAL
Intervention: Blood sample collection (five tubes)
Description: Collection of five tubes of 7.5 ml blood in addition to a blood sample made in clinical practice
Study: NCT04537832

Intervention type: OTHER
Intervention: No Intervention
Description: No Intervention
Study: NCT05308498

Intervention type: DIAGNOSTIC_TEST
Intervention: ESView software with proscan
Description: Each reviewer will review random video and record all lesions/findings with the ESView software with ProScan.

Intervention type: DIAGNOSTIC_TEST
Intervention: Rapid software with SBI
Description: Each reviewer will review random video and record all lesions/findings with the PillCam Rapid software with SBI.
Study: NCT05133869

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Metacognitive training + direct training
Description: The intervention will consist of a combination of direct training of the impaired cognitive function(s) and metacognitive strategy training for 42 days (6 weeks). Direct training will be done with the computer program Rehacom for 20 minutes, 5 times a week. Metacognitive strategy training will be given on a weekly or biweekly basis (6-10 sessions) by a trained therapist at Adelante.~Rehacom is a brain training program developed to improve a variety of cognitive functions with the use of game-like cognitive training modules. During the intervention the participant should train with Rehacom for approximately 600 minutes in total.~In addition to the direct training, the participant receives six to ten sessions of metacognitive strategy training. During this training they are taught strategies by a therapist to improve their performance on the Rehacom modules and on daily life functioning. Each metacognitive strategy is linked to one of the Rehacom modules.
Study: NCT06206135

Intervention type: DRUG
Intervention: the low-dose group (1.5 g/day) or the standard-dose group (4 g/day)
Description: The initial dose of Nephoxil capsules for the subjects participating in this study shall be determined at the investigator's discretion, and subjects shall be classified into either the low-dose group (1.5 g/day) or the standard-dose group (4 g/day) according to the initial dose. It will be conducted with 13 visits over 48 weeks.

Intervention type: DRUG
Intervention: the low-dose group (1.5 g/day) or the standard-dose group (4 g/day)
Description: The initial dose of Nephoxil capsules for the subjects participating in this study shall be determined at the investigator's discretion, and subjects shall be classified into either the low-dose group (1.5 g/day) or the standard-dose group (4 g/day) according to the initial dose. It will be conducted with 13 visits over 48 weeks.